Metaphore Pharmaceuticals
Latest round
- Series D
Last raised
- Aug 2004
Total raised
- $40M
Investors
- 5
About Metaphore Pharmaceuticals
Metaphore Pharmaceuticals discovers and develops drugs that prevent and treat pain and inflammation. Its products are used for the treatment of inflammation and pain, dermatitis, adjunctive oncology therapy, refractory hypotension, and reperfusion injury.
Who invested in Metaphore Pharmaceuticals
5 investors across 1 round
See all investors in Metaphore Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Aug 25, 2004
Amount
$40M
Investors
Questions about Metaphore Pharmaceuticals
Who invested in Metaphore Pharmaceuticals?
Metaphore Pharmaceuticals has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Metaphore Pharmaceuticals raised?
Metaphore Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Metaphore Pharmaceuticals last raise money?
Metaphore Pharmaceuticals's most recent round on record is a Series D, in Aug 2004.
What does Metaphore Pharmaceuticals do?
Metaphore Pharmaceuticals discovers and develops drugs that prevent and treat pain and inflammation.
Where is Metaphore Pharmaceuticals headquartered?
Metaphore Pharmaceuticals is headquartered in Fort Lee, US.
Which VCs invest in companies like Metaphore Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Metaphore Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Metaphore Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.